
CAS 113502-55-9
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
8 Produkte.
Ketorolac Related Compound D (5-benzoyl-2,3-dihydro-1H-pyrrolizine)
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Formel:C14H13NOFarbe und Form:White Light Brown PowderMolekulargewicht:211.09971Ketorolac EP Impurity I (Ketorolac USP Related Compound D)
CAS:Formel:C14H13NOFarbe und Form:White To Off White SolidMolekulargewicht:211.261-Descarboxy Ketorolac
CAS:Kontrolliertes Produkt<p>Applications 1-Descarboxy Ketodolac is an impurity in the synthesis of (R)-Ketorolac (K235600). The (S)-enantiomer is about 60 times more potent than (R)-enantiomer. Prostaglandin biosynthesis inhibitor. Analgesic; anti-inflammatory.<br>References Rooks, W.H., et al.: Agents Actions, 12, 684 (1982), Guzman, A., et al.: J. Med. Chem., 29, 589 (1986), McQuary, H.J., et al.: Clin. Pharmacol. Ther., 39, 89 (1986),<br></p>Formel:C14H13NOFarbe und Form:Yellow To Dark GreyMolekulargewicht:211.261-Descarboxy Ketorolac-d4
CAS:Kontrolliertes ProduktFormel:C14D4H9NOFarbe und Form:NeatMolekulargewicht:215.284Ketorolac Related Compound D
CAS:<p>Ketorolac Related Compound D is a racemic mixture of the optical isomers of ketorolac, which are 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. Ketorolac Related Compound D is used as a pharmaceutical dosage form in intranasal and intranasal formulations. It has been shown to be an effective analgesic for pain relief, with the advantage of having a quick onset and short duration of action. This drug is not active when taken orally because it is not absorbed from the gastrointestinal tract. Excipients such as lactose monohydrate, magnesium stearate and talc are added to the formulation to facilitate processing and to maintain stability.</p>Formel:C14H13NOReinheit:Min. 95%Molekulargewicht:211.26 g/mol







